1. Home
  2. Vol 8, No 1
  3. Pebrianti

Manajemen Cairan Pada Pasien Dengan Diabetes Ketoasidosis (DKA): Literatur Review

Sandra Pebrianti(1), Bambang Aditya Nugraha(2), Iwan Shalahuddin(3*), Theresia Eriyani(4)
(1) Fakultas Keperawatan Unpad
(2) Fakultas Keperawatan Unpad
(3) Fakultas Keperawatan Unpad
(4) Fakultas Keperawatan Unpad
(*) Corresponding Author
DOI : 10.30604/jika.v8i1.1655

Abstract

DKA is a state of decompensation of metabolic chaos characterized by triassic hyperglycemia, acidosis, and ketosis which is one of the most serious and life-threatening acute complications of metabolic diabetes mellitus. Diabetic Ketoacidosis (DKA) requires proper treatment and immediate treatment. Management of insulin therapy, intravenous administration of fluids is a key component of DKA management to expand intravascular, interstitial, and intracellular volumes. This Literature Review aims to determine the influence of fluid management in patients with diabetes ketoacidosis. The author uses the method used to conduct a literature review is to search through the internet. Search literature through the internet based on several criteria, namely journals published in the last 10 years. The literature search uses the PubMed, Sage Journals, and Science Direct databases. Keywords used ''Fluid Management AND Diabetes Ketoacidosis (DKA)''. Then sorted by inclusion criteria, publication year 2017-2022, experimental research design, and written in Indonesian or uk. Based on the results of the study, it can be concluded that there are six fluid administration interventions in Diabetes Ketoacidosis (DKA) patients, namely crystalloid fluid, saline fluid, lyte-148 plasma, potassium, plasma lyte A and the use of two fluids (electrolyte fluid + dextrose). DKA management includes adequate replacement of fluids and electrolytes, especially potassium, as well as continuous administration of insulin. The top priority in the management of DKA is one of them is fluid therapy.

Keywords


Diabetes Ketoacidosis (DKA); Fluid Management; Patients

References


Allen, C. H., Goldman, R. D., Bhatt, S., Simon, H. K., Gorelick, M. H., Spandorfer, P. R., ... & Goldstein, S. L. (2016). A randomized trial of Plasma-Lyte A and 0.9% sodium chloride in acute pediatric gastroenteritis. BMC pediatrics, 16(1), 1-9.

Becherucci, F., Roperto, R. M., Materassi, M., & Romagnani, P. (2016). Chronic kidney disease in children. Clinical kidney journal, 9(4), 583-591.

Besen, B. A. M. P., Boer, W., & Honore, P. M. (2021). Fluid management in diabetic ketoacidosis: new tricks for old dogs?. Intensive Care Medicine, 47(11), 1312-1314.

Carrillo, A. R., Elwood, K., Werth, C., Mitchell, J., & Sarangarm, P. (2022). Balanced Crystalloid Versus Normal Saline as Resuscitative Fluid in Diabetic Ketoacidosis. Annals of Pharmacotherapy, 1–9. https://doi.org/10.1177/10600280211063651

Faisal, F., Adelaine, A. T., & Nurhayati, T. (2020). Hubungan Derajat Ketoasidosis Diabetik dengan Kadar Kalium pada Pasien Anak di Rumah Sakit Dr. Hasan Sadikin Periode Tahun 2014-2019. Sari Pediatri, 22(2), 71-75.

Febrianto, D., & Hindariati, E. (2021). Tata Laksana Ketoasidosis Diabetik pada Penderita Gagal Jantung. Jurnal Penyakit Dalam Indonesia, 8(1), 46-53.

Garg, S. K., Peters, A. L., Buse, J. B., & Danne, T. (2018). Strategy for mitigating DKA risk in patients with type 1 diabetes on adjunctive treatment with SGLT inhibitors: a STICH protocol. Diabetes technology & therapeutics, 20(9), 571-575.

Glaser, N., & Kuppermann, N. (2019). Fluid treatment for children with diabetic ketoacidosis: how do the results of the pediatric emergency care applied research network fluid therapies under investigation in diabetic ketoacidosis (fluid) trial change our perspective?. Pediatric Diabetes, 20(1), 10-14.

Goldenberg, R. M., Gilbert, J. D., Hramiak, I. M., Woo, V. C., & Zinman, B. (2019). Sodium?glucose co?transporter inhibitors, their role in type 1 diabetes treatment and a risk mitigation strategy for preventing diabetic ketoacidosis: the STOP DKA protocol. Diabetes, Obesity and Metabolism, 21(10), 2192-2202.

Guise, R., Ausherman, K., & Vazifedan, T. (2021). Potassium-Containing Fluids for Diabetic Ketoacidosis. The Journal of Pediatric Pharmacology and Therapeutics, 26(6), 592-596.

Haas, N. L., Gianchandani, R. Y., Gunnerson, K. J., Bassin, B. S., Ganti, A., Hapner, C., ... & Whitmore, S. P. (2018). The two-bag method for treatment of diabetic ketoacidosis in adults. The Journal of emergency medicine, 54(5), 593-599.

Hom, J., & Sinert, R. (2008). Evidence-based emergency medicine/critically appraised topic. Is fluid therapy associated with cerebral edema in children with diabetic ketoacidosis?. Annals of Emergency Medicine, 52(1), 69-75.

Ismail, M. T., & Elbaih, A. H. (2020). Principles of intravenous fluids therapy. EC Emerg Med Critical Care, 4(6), 24-46.

Makris, K., & Spanou, L. (2016). Acute kidney injury: definition, pathophysiology and clinical phenotypes. The clinical biochemist reviews, 37(2), 85.

Oliver, W. D., Willis, G. C., Hines, M. C., & Hayes, B. D. (2018). Comparison of Plasma-Lyte A and Sodium Chloride 0.9% for Fluid Resuscitation of Patients With Diabetic Ketoacidosis. Hospital Pharmacy, 53(5), 326–330. https://doi.org/10.1177/0018578718757517

Price, A. Wilson. 2006. Patofisiologi Konsep Proses-Proses Penyakit, Edisi IV. Jakarta: EGC.

Ramanan, M. et al. (2021) ‘Sodium chloride or Plasmalyte ? 148 evaluation in severe diabetic ketoacidosis ( SCOPE ? DKA ): a cluster , crossover , randomized , controlled trial’. doi:10.1007/s00134-021-06480-5.

S., Niswender, K. D., Slovis, C. M., Stollings, J. L., Wang, L., Rice, T. W., & Semler, M. W. (2020). Clinical Effects of Balanced Crystalloids vs Saline in Adults With Diabetic Ketoacidosis: A Subgroup Analysis of Cluster Randomized Clinical Trials. JAMA Network Open, 3(11), 1–13.

Self, W. H., Evans, C. S., Jenkins, C. A., Brown, R. M., Casey, J. D., Collins, S. P., ... & Pragmatic Critical Care Research Group. (2020). Clinical effects of balanced crystalloids vs saline in adults with diabetic ketoacidosis: a subgroup analysis of cluster randomized clinical trials. JAMA network open, 3(11), e2024596-e2024596.

Velasco, J., Fogel, J., Levine, R., Ciminera, P., Fagan, D., & Bargman, R. (2017). Potential clinical benefits of a two-bag system for fluid management in pediatric intensive care unit patients with diabetic ketoacidosis. Pediatric Endocrinology Diabetes and Metabolism, 23(1), 6-13.

Veltri, K. T., & Mason, C. (2015). Medication-induced hypokalemia. Pharmacy and Therapeutics, 40(3), 185.

Von Oettingen, J. E., Rhodes, E. T., & Wolfsdorf, J. I. (2018). Resolution of ketoacidosis in children with new onset diabetes: evaluation of various definitions. Diabetes research and clinical practice, 135, 76-84.

Wolfsdorf, J. I., Glaser, N., Agus, M., Fritsch, M., Hanas, R., Rewers, A., ... & Codner, E. (2018). ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatric diabetes, 19, 155-177.


Article Statistic

Abstract view : 1807 times
PDF (Bahasa Indonesia) views : 1455 times

Dimensions Metrics

How To Cite This :

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.